Attention investors! Zacks Rank #1 (Strong Buy) List just dropped its latest bombshells. Keep your eyes peeled for these potential game-changers:
Toyota Motor Corporation TM: Buckle up for this ride. This automobile company’s Zacks Consensus Estimate for its current year earnings has surged by a stellar 14.3% over the last 60 days.
Toyota Motor Corporation Price and Consensus
Toyota Motor Corporation price-consensus-chart | Toyota Motor Corporation Quote
Paymentus Holdings, Inc. PAY: Cloud billing solutions are taking off! The Zacks Consensus Estimate for this company’s current year earnings has shot up by an impressive 17.7% over the last 60 days.
Paymentus Holdings, Inc. Price and Consensus
Paymentus Holdings, Inc. price-consensus-chart | Paymentus Holdings, Inc. Quote
W. R. Berkley Corporation WRB: Sailing through the market with its insurance prowess, this company’s Zacks Consensus Estimate for its current year earnings is up by a respectable 6% over the last 60 days.
W.R. Berkley Corporation Price and Consensus
W.R. Berkley Corporation price-consensus-chart | W.R. Berkley Corporation Quote
monday.com Ltd. MNDY: It’s time to get on board with this hot software solutions company. The Zacks Consensus Estimate for its current year earnings has climbed by an appealing 7.6% over the last 60 days.
monday.com Ltd. Price and Consensus
monday.com Ltd. price-consensus-chart | monday.com Ltd. Quote
ImmunoGen, Inc. IMGN: Get ready for an explosive journey with this biotech powerhouse. The Zacks Consensus Estimate for its current year earnings has sky-rocketed by an incredible 158.3% over the last 60 days.
ImmunoGen, Inc. Price and Consensus
ImmunoGen, Inc. price-consensus-chart | ImmunoGen, Inc. Quote
Zacks Names “Single Best Pick to Double”
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s credited with a “watershed medical breakthrough” and is developing a bustling pipeline of other projects that could make a world of difference for patients suffering from diseases involving the liver, lungs, and blood. This is a timely investment that you can catch while it emerges from its bear market lows.
It could rival or surpass other recent Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.